INDUSTRY TRENDS

Laboratory Initiation of Cascade Genetic Testing Spurs Uptake

A laboratory-initiated, online effort to reach cancer patients' relatives coupled with discounted genetic tests can increase rates of cascade testing, according to a study published in the January … [Read more...]

EMERGING TESTS

Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy

Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to a study … [Read more...]

CAPITAL

Investment Trends: Dx/Tools Venture Capital Keeps Flowing Despite Decline in Early-Stage Investment

Continuing a four-year trend, total U.S. venture capital investment in health care surged in 2018, reaching a new all-time high of $9.6 billion, according to Silicon Valley Bank's (SVB) Trends in … [Read more...]

INDUSTRY TRENDS

Point-of-Care PCR Tests Better Diagnosis, Rx for Kids’ Sore Throats

Given we are still in the midst of cold and flu season, a new study highlights the benefit of point-of-care (POC) polymerase chain reaction (PCR) testing among pediatric patients presenting to the … [Read more...]

INDUSTRY TRENDS

Diagnostics Sector Saw Increased Investment, Exits in 2018

Life science and health care companies had a banner year in 2018, with a record-breaking year for venture capital investment, according to Silicon Valley Bank's Trends in Healthcare Investments and … [Read more...]

INDUSTRY TRENDS

Despite 23andMe Authorization, FDA Cautious About PGx Testing

The U.S. Food and Drug Administration (FDA) provided 23andMe (Mountain View, Calif.) authorization for the first direct-to-consumer (DTC) test for detecting genetic variants that may be associated … [Read more...]

TESTING STRATEGY

FDA Enabling New Point-of-Care Tests for Ebola Outbreak, Flu Season

Several recent U.S. Food and Drug Administration (FDA) actions are bringing point-of-care (POC) infectious disease tests closer to patient care. These recent regulatory wins are enabling more rapid … [Read more...]

INDUSTRY TRENDS

One-Fourth of Myriad’s Variants of Unknown Significance Reclassified Over 10 Years

Variant reclassification following hereditary cancer genetic testing is common, according to a study published by Myriad Genetics (Salt Lake City) Sept. 25 in the Journal of the American Medical … [Read more...]

INDUSTRY TRENDS

Industry Report: Venture Capitalists Remain High on Healthcare

Healthcare startups remain highly attractive to venture capitalists drawing $10.6 billion in investments in the first half of 2018, the most of any industry sector other than internet companies and … [Read more...]

PRECISION MEDICINE

Report Finds Genetic Tests and Their Reimbursement Increasingly Complex

The health care technology company Concert Genetics (formerly NextGxDx; Nashville, Tenn.) recently released its third edition of The Current Landscape of Genetic Testing, a comprehensive report … [Read more...]


(-00000g2)